Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma

Molecular Therapy — Oncolytics(2022)10.1016/j.omto.2022.03.010Source: DataRank Database

miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma is a research paper published in Molecular Therapy — Oncolytics (2022). On theSindex it has a DataRank of 0. It has been cited 37 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access37 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 3.98)OA: goldTopics (21)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Philip Prathipati ORCID,Omalla A. Olwenyi,Srinivas Chava,Oghenetejiri V. Smith,Subash C. Gupta ORCID

Live enrichment

PubMed:35663229 PMC:PMC9133764 OpenAlex:https://openalex.org/W4220736375

National Cancer Institute

Grant: CA036727

National Cancer Institute

Grant: CA197074

NCI NIH HHS

Grant: P30 CA036727

NCI NIH HHS

Grant: K22 CA197074

FWCI

3.98

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S2372770522000523/pdf

publisherhttp://www.cell.com/article/S2372770522000523/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2372770522000523?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2372770522000523?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.omto.2022.03.010

Fields of Study

Neuroblastoma Research and TreatmentsImmune Cell Function and InteractionLung Cancer Research Studies

Keywords

NeuroblastomaImmune systemCancer researchCD8Cytotoxic T cellChemistryBiologyImmunologyCell cultureBiochemistrySurvivalChemotherapyNatural killer cellsPD-L1miRNAsAnti-tumor immune responseCd8+t CellsPatient-derived Xenografts

Sustainable Development Goals

SDG 0: Good health and well-being